학술논문

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial
Document Type
Article
Source
In Annals of Oncology August 2014 25(8):1622-1628
Subject
Language
ISSN
0923-7534